Z-1371-2016 Class II Terminated

Recalled by Maquet Cardiovascular Us Sales, Llc — Wayne, NJ

FDA device recall Z-1371-2016 was initiated by Maquet Cardiovascular Us Sales, Llc on Feb 23, 2016 and is designated Class II. Reason for recall: Maquet Cardiopulmonary (MCP) is conducting a voluntary recall based on the potential risk of exposure to endotoxin for various products. The recall status is terminated (terminated Sep 25, 2019). Affected quantity: 72,000 units in total.

Recall details

Product Type
Devices
Report Date
Apr 20, 2016
Initiation Date
Feb 23, 2016
Termination Date
Sep 25, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
72,000 units in total

Product description

QUADROX-i oxygenators Custom tubing packs for the oxygenator

Reason for recall

Maquet Cardiopulmonary (MCP) is conducting a voluntary recall based on the potential risk of exposure to endotoxin for various products.

Distribution pattern

US Nationwide Distribution.

Code information

All sizes and membrane types of QUADROX-i oxygenators, QUADROX-i(D) Adult, Small Adult, Pediatric and Neonatal with SOFTLINE and BIOLINE Coating; BE-HMOD xxxxx, BEQ-HMO xxxxx, BEQ-HMOD xxxxx, BO-VKMO xxxxx, HMO xxxxx, HMOD xxxxx, VKMO xxxxx, X HMO xxxxx U, X HMOD 30000 U, X VKMO xxxxx U, and X 1895. QUADROX-iR with SOFTLINE and BIOLINE Coating; XVIVO HMO 70100

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1371-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1371-2016. Report a data issue: hello@regdatalab.com.